Data / Form D filings / RQx Pharmaceuticals, Inc.
RQx Pharmaceuticals, Inc.: Form D filings
RQx Pharmaceuticals, Inc., a pharmaceuticals company in La Jolla, CA, filed 2 Form D notices with the SEC between 2010 and 2011. The latest, on February 17, 2011, reports $1.2 million sold of a $7 million offering to 3 investors.
Find out what RQx Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 11099 N. TORREY PINES ROAD, SUITE 290, La Jolla, CA, 92037
- Phone
- (858) 768-7826
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2010
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1507544
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 17, 2011 | Amendment | $7,000,050 | $1,191,716 | $5,808,334 | 3 | Feb 1, 2011 | sec.gov |
| Dec 10, 2010 | New notice | $7,000,000 | $1,025,000 | $5,975,000 | 2 | Nov 19, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jay A. Litcher | Director | |
| Court R. Turner | Executive Officer, Director | |
| Floyd A. Romesberg | Director | |
| Thomas A. Coll | Executive Officer | |
| Douglas R. Downs | Executive Officer |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Feb 14, 2011 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what RQx Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.